Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Appendix cancer, once rare, is now rising sharply among younger people. Firstpost brings out an expert’s views on the risk ...

Anita Turk, MD, discusses the unmet needs that still exist in the realm of colorectal cancer treatment and management.

I had a symptom of colon cancer and family history, so I got a colonoscopy. It was expensive, and insurance was a nightmare, ...

Appendix cancer is a rare but increasingly recognized malignancy, often discovered incidentally during surgery for presumed ...

Cancer patients receiving immune checkpoint inhibitor (ICI) therapy may experience more severe toxicity and have a greater risk of death if they have recently used proton pump inhibitors (PPIs), ...

Three of five patients with advanced colorectal cancer responded to leronlimab, including one complete response lasting five years, according to new data.

Cancer is often linked to old age. Many people think it happens late in life. But a quiet shift is happening now, especially with cancers in your stomach and bowels. It isn’t just an old person’s ...

A stomach pain is usually harmless However if the discomfort continues and lingers on for weeks it could indicate serious ...

CytoDyn announces encouraging clinical findings among patients with advanced metastatic colorectal cancer previously treated with leronlimab: Vancouver, Washington Friday, July 4, ...

A new study from Weill Cornell Medicine-Qatar (WCM-Q), a member of Qatar Foundation, is drawing global attention for its ...

Monotherapy efficacy and safety profile provided backbone for clinical development strategy in 1L combination with nivolumab ...